Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1β, and IL-8: Markers of remission in rheumatoid arthritis during treatment with methotrexate

Journal of Rheumatology

Volumn 23, Issue 9, 1996, Pages 1512-1516

  Seitz, Michael ^a   Loetscher, Pius ^a   Dewald, Beatrice ^b   Towbin, Harry ^c   Rordorf, Christiane ^c   Gallati, Harald ^d   Gerber, Niklaus J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c CIBA GEIGY LTD   (Switzerland)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Cytokine inhibitors; Cytokines; Disease Remission; Methotrexate; Rheumatoid arthritis

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 8; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR; REMISSION INDUCTION; SOLUBILITY;

EID: 0029740907     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lipsky PE, Davis LS, Cush JJ, Oppenheimer-Marks N: The role of cytokines in the pathogenesis of rheumatoid arthritis. Springer Semin Immunopathol 1989;11:123-62.
2. Dayer JM, Fenner H: The role of cytokines and their inhibitors in arthritis. Ballière's Clin Rheumatol 1992;6:455-516.
3. Firestein GS, Alvaro Gracia JM, Maki R: Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990;144:3347-53.
4. Wood NC, Symons JA, Dickens E, Duff GW: In situ hybridization of IL-6 in rheumatoid arthritis. Clin Exp Immunol 1992;87:183-9.
5. Chu CQ, Field M, Feldmann M, Maini RN: Localization of tumor necrosis factor α in synovial tissues and the cartilage pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-32.
6. Koch AE, Kunkel SL, Burrows JC, et al: Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 1991;147:2187-95.
7. Roux-Lombard P, Modoux C, Vischer T, Grassi J, Dayer JM: Inhibitors of interleukin 1 activity in synovial fluids and in cultured synovial fluid mononuclear cells. J Rheumatol 1992;19:517-23.
8. Towbin H, Schmitz A, van Oostrum J, et al: Monoclonal antibody based enzyme-linked and chemiluminescent assays for the human interleukin-1 receptor antagonist. Application to measure hIL-Ra levels in monocyte cultures and synovial fluids. J Immunol Methods 1994;170:125-35.
9. Roux-Lombard P, Punzi L, Hasler F, et al: Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. Arthritis Rheum 1995;36:485-9.
10. Miltenburg AMM, Aderka D, van Laar JM, Wallach D, Breedveld FC: Levels of soluble receptors for tumor necrosis factor type I and type II in paired synovial fluids of arthritis patients. Rheumatol Int 1993;13:117-9.
11. Firestein GS, Boyle DL, Yu C, et al: Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 1994;37:644-52.
12. Barrera P, Boerbooms AMT, Janssen EM, et al: Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor α and interleukin-6 levels in rheumatoid arthritis. Arthritis Rheum 1993;36:1070-9.
13. Koski JR, Poplak DG, Blaese RMA: Nonspecific esterase stain for the identification of monocytes and macrophages. In: Bloom CBR, David FR, eds: In Vitro Methods in Cell Mediated and Tumor Immunity. New York: Academic Press, 1976:359.
14. Häupl T, Burmester GR, Hahn G, Feige U, Rordorf-Adam C, Kalden JR: Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: Inhibition of interleukin-1 release by the B 95-8, but not the P3HR-1 virus strain. Rheumatol Int 1989;9:153-60.
15. Elsässer-Beile U, von Kleist S, Stähle W, Schurhammer-Fuhrmann C, Schulte-Monting J, Gallati H: Cytokine levels in whole blood cell cultures as parameters of the cellular immunologic activity in patients with malignant melanoma and basal carcinoma. Cancer 1993;71:231-6.
16. Heilig B, Wermann M, Gallati H, et al: Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis. Clin Invest 1992;70:22-8.
17. Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M: Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin-8. J Exp Med 1991;173:771-4.
18. Loetscher P, Dewald B, Baggiolini M, Seitz M: Monocyte chemoattractant protein-1 and interleukin-8 production by rheumatoid synoviocytes. Effects of antirheumatic drugs. Cytokine 1994;6:162-70.
19. Thanas R, Carrol GJ: Reduction of leukocyte and interleukin-1ß concentrations in the synovial fluid of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 1993;36:1244-52.
20. Saxne T, Palladino MA, Heinegard D, Talal N, Wolheim FA: Detection of tumor necrosis factor α but not of tumor necrosis factor ß in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-5.
21. Seitz M, Dewald B, Ceska M, Gerber NJ, Baggiolini M: Interleukin-8 in inflammatory rheumatic diseases: Synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol Int 1992;12:159-64.
22. Koch AE, Kunkel SL, Harlow LA, et al: Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 1992;90:772-9.
23. Darbonne WC, Rice GC, Mohler MA, et al: Red blood cells are a sink for interleukin-8, a leukocyte chemotaxin. J Clin Invest 1991;88:1362-9.
24. Brennan FM, Gibbons DL, Mitchell T, Cope AP, Maini RN, Elldmann M: Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints. Eur J Immunol 1992;22:1907-12.
25. Leeuwenberg JFM, Jeunhomme TMAA, Buurman WA: Slow release of soluble TNF receptors by monocytes in vitro. J Immunol 1994;152:4036-43.
26. Seitz M, Loetscher P, Dewald B, Towbin H, Gallati H, Baggiolini M: Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur J Immunol 1995;25:1129-32.
27. Seitz M, Dewald B, Gerber N, Baggiolini M: Enhanced production of neutrophil activating peptide-1/interleukin-8 in rheumatoid arthritis. J Clin Invest 1991;87:463-9.
28. Seitz M, Loetscher P, Dewald B, et al: Methotrexate action in rheumatoid arthritis. Stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells. Br J Rheumatol 1995;34:602-9.